Core Insights - Jushi Holdings Inc. has opened its 43rd retail location nationwide and the 7th Beyond Hello dispensary in Ohio, specifically in Northern Cincinnati [2][7][10] - The grand opening celebration is scheduled for January 23, 2026, featuring exclusive promotions for customers [9][10] Company Expansion - The new dispensary is strategically located along the Springfield Pike corridor, providing easy access for residents and commuters in the greater Cincinnati area [5] - Jushi continues to expand its vertically integrated operations in Ohio, cultivating and manufacturing a portfolio of in-house brands [10] Product Offering - The dispensary will offer a wide selection of premium cannabis products, including flower, vapes, concentrates, edibles, and wellness options [6] - Customers will receive support from a knowledgeable team of cannabis professionals dedicated to education and personalized service [6]

Core Viewpoint - The investment thesis for Village Farms International (VFF) stock is based on a fundamental dislocation in the cannabis market, indicating that the company has achieved a significant milestone in cannabis economics [1] Group 1 - Village Farms has reached what is referred to as the "Holy Grail" of cannabis economics, suggesting a strong potential for growth and profitability in the sector [1]

Core Insights - The company expects Q4 net revenue, excluding discontinued businesses, to be at least $330 million, indicating approximately 4% sequential growth from Q3 2025's net revenue of $317.8 million, surpassing previous guidance of low single-digit growth [1] - Q4 net revenue is projected to grow about 1% compared to Q4 2024's net revenue of $327.8 million [1] - The adjusted gross profit margin for Q4, excluding discontinued businesses, is anticipated to be around 48.5%, consistent with the comparable margin for Q4 2024 [1] - The full year 2025 adjusted gross margin is expected to be approximately 50% [1] Strategic Decisions - The company has decided to wind down its hemp business due to new federal regulations that prohibit hemp-derived THC products containing THC above 0.3% [1] - The exit from Missouri is also part of the strategy, as the sub-scale presence in the state did not justify continued investment [1] Future Outlook - The preliminary Q4 results indicate that the "Return to Our Roots" strategy has positively impacted revenue growth and maintained strong margins [1] - The company aims to close the year on a high note, establishing a solid foundation for renewed momentum and performance in 2026 [1] - There is a focus on maintaining a robust balance sheet while completing the refinancing of senior secured notes due December 2026, guided by a comprehensive capital allocation and liquidity strategy [1]

Core Insights - The Roundhill Cannabis ETF (BATS:WEED) has experienced a significant increase in technical strength, with its momentum ranking reaching the 89th percentile this week due to renewed optimism for federal cannabis reform [1][2]. Momentum Analysis - The Roundhill ETF's momentum score is reported at 89.25, significantly outperforming industry peers like Aurora Cannabis Inc. (NASDAQ:ACB), which has a momentum score of 21.25 [2]. - This momentum metric is crucial for traders as it reflects the ETF's relative strength based on price movement patterns and volatility over various timeframes, indicating strong investor confidence [3]. Long-Term Outlook - Despite the short-term surge in momentum, the technical outlook is mixed; while the ETF shows positive trends in the short and long term, the medium-term trend remains negative according to Benzinga Edge's Stock Rankings [4]. Regulatory Impact - The primary catalyst for this momentum is the evolving regulatory environment, particularly President Trump's initiative to reschedule cannabis to Schedule 3, which is considered a significant policy shift in 50 years [6]. - Rescheduling to Schedule 3 would alleviate the tax burdens imposed by Section 280E, enhancing the profitability of U.S. cannabis operators [7]. Performance Metrics - The WEED ETF has seen a decline of 4.72% in 2026 thus far, but it has increased by 61.50% over the last six months and 26.17% over the past year [8].

The opening marks the Company's only adult-use location in Maine STAMFORD, Conn., Jan. 21, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of an adult-use store adjacent to the medical dispensary located at 829 Hogan Rd., Bangor, Maine. With this opening, Curaleaf expands to five retail locations in Maine, and 161 nationwide. Conveniently situated near the Bangor ...

Core Viewpoint - Tilray Brands has shown some improvement in its financial performance, with a significant increase in international cannabis sales and a reduction in operating losses, but overall growth remains inconsistent and the company continues to face challenges in the cannabis market [1][2][4]. Financial Performance - The company reported a record revenue of $217.5 million for the second quarter of fiscal 2026, marking a 3% increase year over year [2]. - International medical cannabis sales surged by 36%, while beverage sales declined by 21% to $50.1 million [3]. - Operating loss was reduced to $22.3 million from $42.2 million a year ago, attributed to a decline in restructuring costs and amortization expenses [4]. Market Context - The cannabis industry remains volatile, with the potential for short-term gains driven by market excitement, but long-term investment prospects are uncertain [9][10]. - Recent regulatory changes, such as President Trump's executive order to reschedule marijuana, may facilitate research and reduce tax burdens, but do not significantly enhance growth prospects for companies like Tilray [7][8]. Growth Prospects - Despite some positive indicators, Tilray's growth has been inconsistent, often reliant on acquisitions for short-term boosts rather than sustainable organic growth [6]. - The lack of consistent growth and ongoing uncertainty in the cannabis market make Tilray a risky investment, appealing primarily to speculative investors [9][11].

Core Viewpoint - President Trump's executive order to reschedule cannabis to Schedule 3 is considered a significant shift in federal cannabis policy, potentially alleviating the burdensome tax regime on American cannabis operators [1]. Financial Implications - The executive order may lead to the elimination of Section 280E of the Internal Revenue Code, which currently taxes legal cannabis operators as if they were narcotics traffickers, preventing them from deducting any business expenses [2][3]. - Rescheduling cannabis to Schedule 3 would allow U.S. companies to deduct standard operating costs, significantly improving their financial health and cash flow profiles [3]. Market Reaction - The cannabis industry is responding positively to the news, especially after a strong performance in 2025, where the AdvisorShares MSOS ETF outperformed the S&P 500 [4]. Investment Volatility - Despite the positive developments, the cannabis sector remains highly volatile, with many institutional investors hesitant due to past political inaction. A market "pop" is anticipated upon finalization of the rescheduling, but this is viewed as just the initial step in a longer reform process [5]. Remaining Challenges - Even with the potential rescheduling, U.S. cannabis companies still face hurdles, such as the inability to list on major exchanges like NASDAQ or NYSE, which is available to Canadian companies. Additionally, the industry is still awaiting "safe harbor" provisions for banking [6].

Industry Overview - The cannabis industry is experiencing significant changes in 2026, with high speculation about its future, particularly in the U.S. and Canada, which are leading the sector [1][2] - The recent rescheduling of cannabis to a class 3 substance by the federal government in the U.S. is expected to facilitate further testing and expansion without federal concerns, potentially benefiting companies in the industry [2][3] Company Highlights - **Green Thumb Industries Inc. (GTBIF)**: - The company reported Q3 2025 earnings with a revenue of $291.4 million, reflecting a 1.6% increase year-over-year [9] - Cash at the end of the quarter was $226.2 million, with a GAAP net income of $23.3 million, or $0.10 per share [9] - Adjusted EBITDA was $80.2 million, representing 27.5% of revenue, and cash flow from operations was $74.1 million [9] - **Greenlane Holdings, Inc. (GNLN)**: - Engages in the development and distribution of cannabis accessories and lifestyle products across multiple regions including the U.S., Canada, Europe, and Latin America [10][12] - Recently announced that Canopy Growth Co-founder Bruce Linton will join its board of directors [14] - **Curaleaf Holdings, Inc. (CURLF)**: - Expected fourth quarter net revenue for 2025, excluding discontinued businesses, is projected to be at least $330 million [15][16] - Anticipated adjusted gross profit margin for the fourth quarter, excluding discontinued businesses, is approximately 48.5% [16]

Core Insights - The cannabis industry is evolving with increasing legalization in the U.S., and ancillary cannabis companies are emerging as attractive investment opportunities due to fewer regulatory hurdles compared to plant-touching operators [1] Group 1: GrowGeneration Corp. (GRWG) - GrowGeneration Corp. is a leading ancillary cannabis company specializing in hydroponic and organic gardening products for cannabis cultivators, operating over twenty retail and distribution locations across major markets like California, Colorado, and Florida [2] - The company has focused on restructuring and margin improvement, showing stabilizing revenue and improved gross margins due to a higher mix of proprietary brands, while also reducing operating expenses [3] - GrowGeneration reported positive adjusted EBITDA recently, marking a significant milestone, and maintains a strong cash position with minimal debt, providing flexibility during industry downturns [3] Group 2: Hydrofarm Holdings Group, Inc. (HYFM) - Hydrofarm Holdings Group manufactures and distributes hydroponic equipment for commercial growers, with a strong presence in West Coast cannabis markets and a broad product portfolio [6] - The company has faced challenges due to industry oversupply, leading to revenue declines and increased losses, but is focusing on restructuring initiatives to stabilize operations [8] - Despite weaker demand, Hydrofarm's brands retain loyalty among professional cultivators, and its diversification into indoor food production markets provides some revenue insulation [8] Group 3: The Scotts Miracle-Gro Company (SMG) - The Scotts Miracle-Gro Company, known for lawn and garden products, has a division called Hawthorne Gardening that supplies hydroponic growers with essential cultivation technology [9] - While Hawthorne's sales have declined due to slowed cultivation, Scotts remains profitable and cash-generative, supported by its core lawn and garden products [10] - The company generates strong free cash flow and has publicly supported cannabis reform initiatives, which could benefit Hawthorne if federal policies shift favorably [10]

Core Insights - Tilray Brands (TLRY) reported a strong international quarterly performance in Q2 of fiscal 2026, with revenues from its international cannabis business increasing by 36% year over year and 51% sequentially to $20 million, despite facing permit challenges and price compression [1][8] Group 1: International Market Performance - The international cannabis market is a key long-term growth driver for Tilray, supported by increasing market opportunities, revenues, and profitability [2] - The company has reduced supply in the Canadian wholesale market to focus on international markets, maintaining a leading position in Canada across various product categories [2][3] - Tilray's cannabis cultivation capacity has increased to 200 metric tons annually, aiding its expansion into fast-growing markets and improving margins [3] Group 2: Product Expansion and New Markets - Tilray is expanding its beverage business globally, with plans to launch HiBall Energy in the U.K. and further expansion into the Middle East and Africa [4] - The company has entered the Quebec market with vapes under the Good Supply brand, quickly achieving top three SKU positions in the province [3] Group 3: Competitive Landscape - Village Farms International's subsidiary, Pure Sunfarms, is launching 10 new products in the Netherlands, reflecting a focus on innovation and competitive differentiation [5] - SNDL Inc. has acquired five cannabis retail stores in Alberta and Saskatchewan, with plans for further acquisitions in Ontario [6] Group 4: Financial Performance and Valuation - Tilray's shares have increased by 40.4% over the past six months, contrasting with a 6.6% decline in the industry [7] - The company is trading at a forward Price-to-Sales (P/S) ratio of 1.22X, which is lower than the industry average of 2.81X [9]